KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Gross Margin: 2016-2024

Historic Gross Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to 36.52%.

  • Amneal Pharmaceuticals' Gross Margin fell 345.00% to 34.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.76%, marking a year-over-year increase of 142.00%. This contributed to the annual value of 36.52% for FY2024, which is 224.00% up from last year.
  • According to the latest figures from FY2024, Amneal Pharmaceuticals' Gross Margin is 36.52%, which was up 6.54% from 34.28% recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Gross Margin ranged from a high of 36.73% in FY2021 and a low of 31.54% during FY2020.
  • Its 3-year average for Gross Margin is 35.42%, with a median of 35.47% in 2022.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Gross Margin spiked by 983bps in 2020, and later crashed by 126bps in 2022.
  • Yearly analysis of 5 years shows Amneal Pharmaceuticals' Gross Margin stood at 31.54% in 2020, then spiked by 519bps to 36.73% in 2021, then plummeted by 126bps to 35.47% in 2022, then tumbled by 119bps to 34.28% in 2023, then soared by 224bps to 36.52% in 2024.